Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
24 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Reckitt Benckiser Pharmaceutical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Reckitt Benckiser Pharmaceutical, Inc. - Product Pipeline Review - 2014', provides an overview of the Reckitt Benckiser Pharmaceutical, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Reckitt Benckiser Pharmaceutical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Reckitt Benckiser Pharmaceutical, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Reckitt Benckiser Pharmaceutical, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Reckitt Benckiser Pharmaceutical, Inc.'s pipeline products Reasons to buy - Evaluate Reckitt Benckiser Pharmaceutical, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Reckitt Benckiser Pharmaceutical, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Reckitt Benckiser Pharmaceutical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Reckitt Benckiser Pharmaceutical, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Reckitt Benckiser Pharmaceutical, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Reckitt Benckiser Pharmaceutical, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Reckitt Benckiser Pharmaceutical, Inc. Snapshot 4 Reckitt Benckiser Pharmaceutical, Inc. Overview 4 Key Facts 4 Reckitt Benckiser Pharmaceutical, Inc.- Research and Development Overview 5 Key Therapeutic Areas 5 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products- Monotherapy 8 Pipeline Products- Partnered Products 9 Partnered Products/Combination Treatment Modalities 10 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline Products Glance 11 Reckitt Benckiser Pharmaceutical, Inc.- Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Reckitt Benckiser Pharmaceutical, Inc.- Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Reckitt Benckiser Pharmaceutical, Inc.- Drug Profiles 13 risperidone SR 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 buprenorphine hydrochloride 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 RBP-8000 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline Analysis 18 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline Products by Target 18 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline Products by Route of Administration 19 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline Products by Molecule Type 20 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline Products by Mechanism of Action 21 Reckitt Benckiser Pharmaceutical, Inc.- Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 24 Disclaimer 24
List of Tables Reckitt Benckiser Pharmaceutical, Inc., Key Facts 4 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline by Indication, 2014 6 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline by Stage of Development, 2014 7 Reckitt Benckiser Pharmaceutical, Inc.- Monotherapy Products in Pipeline, 2014 8 Reckitt Benckiser Pharmaceutical, Inc.- Partnered Products in Pipeline, 2014 9 Reckitt Benckiser Pharmaceutical, Inc.- Partnered Products/ Combination Treatment Modalities, 2014 10 Reckitt Benckiser Pharmaceutical, Inc.- Phase III, 2014 11 Reckitt Benckiser Pharmaceutical, Inc.- Phase II, 2014 12 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline by Target, 2014 18 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline by Route of Administration, 2014 19 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline by Molecule Type, 2014 20 Reckitt Benckiser Pharmaceutical, Inc.- Pipeline Products by Mechanism of Action, 2014 21
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.